RLAY Trading Analysis - 10/06/2026 02:31 PM — TRU-SENTIMENT

News Headlines & Context

Recent general-knowledge context for RLAY (Relay Therapeutics) suggests the following thematic headlines that may frame the trading environment:

• Relay Therapeutics advances precision oncology pipeline with updated Phase 1/2 data readouts expected later in the year, keeping speculative biotech interest elevated.
• Management highlighted cash runway extensions via recent financings, reducing near-term dilution fears but maintaining high cash-burn profile typical of pre-revenue biotech.
• Sector rotation into small-cap biotech on easing rate expectations has provided tailwinds, though clinical trial catalysts remain binary events.
• No confirmed earnings date in embedded data; last fiscal year end was 2025-12-01 per fundamentals, implying next annual disclosure several months out.
• Context: Headlines reflect a pre-revenue, clinical-stage profile; this aligns with negative trailing EPS and high beta (2.04) seen in fundamentals, while options sentiment shows heavy put positioning possibly reflecting hedging around binary risk.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for RLAY:

• Trailing EPS is -1.57, confirming the company is not profitable (pre-revenue clinical-stage biotech).
• Trailing P/E is 18.30; however, with negative earnings, this ratio is not meaningful for valuation and PEG ratio is null.
• Revenue growth, gross/operating/net margins, ROE, debt/equity, and free cash flow are all null in the data — no quantitative strength or concern can be derived beyond loss-making status.
• Institutional ownership is 49.61%, indicating moderate institutional presence.
• Market cap is 4.00B with 219.14M shares outstanding; dividend yield 0.00 (no dividend).
• 52-week range: 5.47 low to 21.27 high; current price near 19.14 sits in upper half of annual range.
• Beta is 2.04 (high volatility relative to market); historical volatility 44.69%.
• Analyst consensus, target mean price, and number of opinions are null — no street context available.
• Fundamentals (loss-making, no margin data) diverge from mildly constructive technicals (price above SMA 5/20) but align with bearish options sentiment reflecting risk aversion.

Current Market Position

From minute bars (2026-10-05 09:30 to 2026-10-06 14:00) and daily history:

Current referenced price in indicators is 19.14 (2026-10-05 close 19.14). Minute bars show 2026-10-05 open 19.00, high 19.06 early, drifting to 18.87 low; by 2026-10-06 14:00 last close 18.29 (intraday pullback). Daily close on 2026-10-05 was 19.14 vs open 19.00, high 19.32, low 18.29, volume 1.63M (below 20-day avg 2.38M).

Intraday momentum: First 5 bars 10-05 show 19.05 → 18.91 softening; last 5 bars 10-06 show 18.23 → 18.29 slight stabilization. Price decoupled from prior day strength, indicating short-term weakness inside broader sideways daily range.

Technical Analysis

SMA alignment: SMA 5 (18.61) ≈ SMA 20 (18.60) and both below SMA 50 (19.11) — no golden cross; price 19.14 is above short-term MAs but below 50-day, showing consolidation under longer resistance. RSI 51.26 is neutral, no extreme momentum. MACD -0.17 below signal -0.13 with hist -0.03 = mild bearish momentum. Bollinger mid 18.60, price 19.14 inside upper half, no squeeze (band width 2.12). 30-day range 17.05–20.77; current 19.14 is ~65% up the range. ATR 0.95 implies daily movement capacity near 5% of price.

True Sentiment Analysis (Delta 40-60 Options)

Options flow via True Sentiment (Delta 40-60 only):

Call Dollar Volume: 10,210.00 (4.40%) Put Dollar Volume: 223,155.00 (95.60%) Total: 233,365.00

Call contracts 27 / Put contracts 474; call trades 4 / put trades 6. Sentiment tag: Bearish. Pure directional conviction heavily favors puts — 95.6% put dollar vol suggests strong downside protection or bearish bets into 2026-11-20. Divergence: technicals neutral (RSI ~51, price above SMA5/20) but sentiment extreme bearish; possible hedging against binary catalyst or anticipated weakness below 19.11 SMA50.

Key Price Levels (Observational Only)